Cardioprotective effect Linagliptin (DPP-4 Inhibitor) against myocardial infarction induced in rats with metabolic syndrome

Ameliorating effect of tocilizumab in letrozole induced polycystic ovarian syndrome in rats via improving insulin resistance and down-regulation of VEGF/ANGPT/PDGF

Protective effect of agomelatine on some cardiovascular and metabolic parameters in experimentally induced type 2 diabetes mellitus in rats

Modulation activity of Vildagliptin on Hepatic Complications and Lipoprotein Abnormalities Associated with Insulin Resistance in Rats

The effect of dipeptidyl peptidase-4 inhibitors or curcumin on diet induced metabolic syndrome with cardiac dysfunction in rats

Aliskiren and L-carnitine attenuate isoproterenol-induced cardiac hypertrophy via targeting IL-6/JAK2/STAT3/SOCS3 signaling pathway

Assessment of SGLT2 Inhibitor, Canagliflozin Effects on Metabolic Syndrome-Induced Cardiovascular Disorders in Rats

The Possible Antidiabetic Effects of Ranolazine Versus Gliclazide In HFD/STZ-Induced Type 2 Diabetes In Male Albino Rats

Pioglitazone protects against acetic acid –induced ulcerative colitis in rats via modulation of SIRT1 / NOX4 signaling and suppression of macrophage M1 polarization

Alagebrium and spironolactone ameliorate dietary induced metabolic syndrome in male Wister rats